What is Artemis Shielding?
Artemis Shielding operates at the intersection of advanced materials science and regulatory compliance, specializing in the development of lead-free, non-toxic radiation shielding solutions. The company addresses critical safety requirements across diverse sectors, including medical imaging, nuclear energy, aerospace engineering, and security testing facilities. By prioritizing recyclable and sustainable materials, Artemis Shielding distinguishes itself from traditional providers, offering a modern alternative that aligns with stringent global health and environmental standards. Their versatile product portfolio is engineered to provide robust protection without the toxicity associated with conventional lead-based shielding, effectively future-proofing their clients against tightening environmental regulations.
How much funding has Artemis Shielding raised?
Artemis Shielding has raised a total of $41K across 1 funding round:
Debt
$41K
Debt (2021): $41K with participation from PPP
Key Investors in Artemis Shielding
PPP
Public-Private Partnership
What's next for Artemis Shielding?
With the infusion of this latest investment, Artemis Shielding is poised to scale its manufacturing capabilities and expand its reach into emerging international markets. The strategic focus will likely center on deepening R&D efforts to enhance the performance of their proprietary shielding materials, ensuring they meet the increasingly complex demands of the aerospace and nuclear sectors. As the company transitions through this significant Series B/C stage, the management team is expected to prioritize operational efficiency and the cultivation of long-term partnerships with major industrial stakeholders. This growth trajectory suggests a clear intent to dominate the sustainable radiation protection market, leveraging their technological edge to displace legacy solutions and set new industry benchmarks for safety and environmental stewardship.
See full Artemis Shielding company page
